| Importance of probiotics in the prevention and treatment of colorectal cancer M Eslami, B Yousefi, P Kokhaei, M Hemati, ZR Nejad, V Arabkari, ... Journal of cellular physiology 234 (10), 17127-17143, 2019 | 252 | 2019 |
| microRNAs: new prognostic, diagnostic, and therapeutic biomarkers in cervical cancer JS Nahand, S Taghizadeh‐boroujeni, M Karimzadeh, S Borran, ... Journal of cellular physiology 234 (10), 17064-17099, 2019 | 175 | 2019 |
| Circulating microRNAs in hepatocellular carcinoma: potential diagnostic and prognostic biomarkers H Reza Mirzaei, A Sahebkar, M Mohammadi, R Yari, H Salehi, ... Current pharmaceutical design 22 (34), 5257-5269, 2016 | 153 | 2016 |
| Long non-coding RNAs as epigenetic regulators in cancer A Vafadar, Z Shabaninejad, A Movahedpour, S Mohammadi, ... Current pharmaceutical design 25 (33), 3563-3577, 2019 | 114 | 2019 |
| Circular RNAs in cancer: new insights into functions and implications in ovarian cancer Z Shabaninejad, A Vafadar, A Movahedpour, Y Ghasemi, A Namdar, ... Journal of ovarian research 12, 1-12, 2019 | 110 | 2019 |
| Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer V Karpisheh, A Nikkhoo, M Hojjat-Farsangi, A Namdar, G Azizi, ... Prostaglandins & other lipid mediators 144, 106338, 2019 | 103 | 2019 |
| Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer N Kheshtchin, S Arab, M Ajami, R Mirzaei, M Ashourpour, N Mousavi, ... Cancer Immunology, Immunotherapy 65, 1159-1167, 2016 | 90 | 2016 |
| CDK1 in breast cancer: implications for theranostic potential S Izadi, A Nikkhoo, M Hojjat-Farsangi, A Namdar, G Azizi, H Mohammadi, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2020 | 82 | 2020 |
| Effect of IFN-ß therapy on the frequency and function of CD4+ CD25+ regulatory T cells and Foxp3 gene expression in relapsing–remitting multiple sclerosis (RRMS): A preliminary … A Namdar, B Nikbin, M Ghabaee, A Bayati, M Izad Journal of neuroimmunology 218 (1-2), 120-124, 2010 | 82 | 2010 |
| Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN–driven CCL5 and CXCL10 C Mowat, SR Mosley, A Namdar, D Schiller, K Baker Journal of Experimental Medicine 218 (9), e20210108, 2021 | 79 | 2021 |
| Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor S Arab, N Kheshtchin, M Ajami, M Ashurpoor, A Safvati, A Namdar, ... Tumor Biology 39 (3), 1010428317695021, 2017 | 77 | 2017 |
| Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine H Hassannia, M Ghasemi Chaleshtari, F Atyabi, M Nosouhian, A Masjedi, ... Immunology 159 (1), 75-87, 2020 | 75 | 2020 |
| CD71+ VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β S Shahbaz, N Bozorgmehr, P Koleva, A Namdar, J Jovel, RA Fava, ... PLoS biology 16 (12), e2006649, 2018 | 69 | 2018 |
| Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway A Masjedi, H Hassannia, F Atyabi, A Rastegari, M Hojjat-Farsangi, ... International journal of biological macromolecules 133, 436-445, 2019 | 67 | 2019 |
| Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine M Esmaily, A Masjedi, S Hallaj, MN Afjadi, F Malakotikhah, S Ghani, ... Journal of Controlled Release 326, 63-74, 2020 | 64 | 2020 |
| Erythroid suppressor cells compromise neonatal immune response against Bordetella pertussis G Dunsmore, N Bozorgmehr, C Delyea, P Koleva, A Namdar, S Elahi The Journal of Immunology 199 (6), 2081-2095, 2017 | 64 | 2017 |
| Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression F Hajizadeh, SM Ardebili, MB Moornani, A Masjedi, F Atyabi, M Kiani, ... European journal of pharmacology 882, 173235, 2020 | 59 | 2020 |
| Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells DM Santer, GES Minty, DP Golec, J Lu, J May, A Namdar, J Shah, S Elahi, ... PLoS pathogens 16 (4), e1008515, 2020 | 55 | 2020 |
| CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis A Namdar, P Koleva, S Shahbaz, S Strom, V Gerdts, S Elahi Scientific reports 7 (1), 7728, 2017 | 51 | 2017 |
| Codelivery of HIF-1α siRNA and dinaciclib by carboxylated graphene oxide-trimethyl chitosan-hyaluronate nanoparticles significantly suppresses cancer cell progression S Izadi, A Moslehi, H Kheiry, F Karoon Kiani, A Ahmadi, A Masjedi, ... Pharmaceutical Research 37, 1-20, 2020 | 45 | 2020 |
